Richard  Glaze net worth and biography

Richard Glaze Biography and Net Worth

Chief Information Officer of CONMED

Mr. Glaze joined the Company as Chief Information Officer in November 2023. Prior to joining CONMED, he served as IT Vice President, North America for Teva Pharmaceuticals (NYSE: TEVA) from August 2020 to November 2023. Prior to working at Teva Pharmaceuticals, Mr. Glaze was the IT Vice President, North America for SUN Pharmaceuticals (NSE: SUNPHARMA) from 2016 to 2020, IT Vice President at Ikaria (now Mallinckrodt Pharmaceuticals, NYSE: MNK) from 2013 to 2016, Sr. IT Director at Hospira (now Pfizer, NYSE: PFE) from 2010 to 2013 and held various positions at Johnson and Johnson (NYSE: JNJ) from 2002 to 2010. Mr. Glaze began his career in consulting, working at Andersen Consulting (now Accenture), Price Waterhouse Coopers, IBM and KPMG Consulting (now BearingPoint) from 1991 to 2002. Mr. Glaze holds a Master of Business Administration degree from the Stern School of Business at New York University, and a Bachelor of Science degree from Princeton University.

How old is Richard Glaze?

Mr. Glaze is currently 58 years old. There are 8 older executives and no younger executives at CONMED. The oldest executive at CONMED is Mr. David R. Murray, President of ConMed Electrosurgery, who is 76 years old. Learn More on Richard Glaze's age.

How do I contact Richard Glaze?

The corporate mailing address for Mr. Glaze and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Richard Glaze's contact information.

Has Richard Glaze been buying or selling shares of CONMED?

Richard Glaze has not been actively trading shares of CONMED in the last ninety days. Most recently, Richard Glaze sold 257 shares of the business's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $65.35, for a transaction totalling $16,794.95. Learn More on Richard Glaze's trading history.

Who are CONMED's active insiders?

CONMED's insider roster includes Martha Aronson (Chair of the Board), Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Richard Glaze (Chief Information Officer), Curt Hartman (Chairman of the Board, CEO & President), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Barbara Schwarzentraub (Director), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.

Are insiders buying or selling shares of CONMED?

In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 4,257 shares worth more than $304,074.95. The most recent insider tranaction occured on February, 11th when insider Richard Glaze sold 257 shares worth more than $16,794.95. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.

Information on this page was last updated on 2/11/2025.

Richard Glaze Insider Trading History at CONMED

See Full Table

Richard Glaze Buying and Selling Activity at CONMED

This chart shows Richard Glaze's buying and selling at CONMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10k$0$10kTotal Insider BuyingTotal Insider Selling

CONMED Company Overview

CONMED logo
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Read More

Today's Range

Now: $48.53
Low: $47.69
High: $48.77

50 Day Range

MA: $58.36
Low: $48.09
High: $64.31

2 Week Range

Now: $48.53
Low: $47.25
High: $78.58

Volume

390,904 shs

Average Volume

462,835 shs

Market Capitalization

$1.50 billion

P/E Ratio

11.45

Dividend Yield

1.67%

Beta

1.28